ONEMEDNET CORPORATION (ONMD) Gross Margin
- Gross margin · 12 months: Value -83.30%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | -83.30% | Gross profit / revenue. Period ending 2026-06-30. $-1.21M ÷ $1.46M × 100 ≈ -83.30% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | -1.21M USD | Gross Profit |
| Revenue | 1.46M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $-1.21M | $1.46M | (m) | -83.30% |
| 2026-03-31 | $-659.00K | $1.32M | (m) | -50.00% |
| 2025-12-31 | $-503.00K | $1.36M | (m) | -37.01% |
| 2025-09-30 | $-694.00K | $494.00K | (m) | -140.49% |
| 2025-06-30 | $-556.00K | $459.00K | (m) | -121.13% |
| 2025-03-31 | $-436.00K | $532.00K | (m) | -81.95% |
| 2024-12-31 | $-281.00K | $643.00K | (m) | -43.70% |
| 2024-09-30 | $-253.00K | $957.00K | (m) | -26.44% |
| 2024-06-30 | $-136.00K | $1.14M | (m) | -11.92% |
| 2024-03-31 | $-109.00K | $1.07M | (m) | -10.20% |
| 2023-12-31 | $-127.90K | $1.02M | (m) | -12.52% |
| 2023-09-30 | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) |
| 2022-12-31 | $-360.69K | $1.15M | (m) | -31.29% |
| 2022-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |